Last reviewed · How we verify
CEFOTIAM HYDROCHLORIDE
At a glance
| Generic name | CEFOTIAM HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1988 |
Approved indications
Common side effects
Key clinical trials
- Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices (NA)
- Efficiency and Safety of Prophylactic Use of Antibiotics in Endoscopic Injection of Tissue Adhesive in Gastric Varices (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CEFOTIAM HYDROCHLORIDE CI brief — competitive landscape report
- CEFOTIAM HYDROCHLORIDE updates RSS · CI watch RSS